Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Explore the detailed record of transactions filed by White William Richard, Chief Financial Officer. Insider active across 3 companies, notably Akero Therapeutics, Inc.. In total, 46 disclosures have been published. Breakdown: 0 buy · 11 sells. Total volume traded: €510k. Activity tracked since 3 May 2021. The latest transaction was filed on 11 September 2025 (Cession). Regulator: SEC (Form 4). All data is accessible without signup.
Companies and markets linked to White William Richard
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
611 shares@ US$20.760.6% of flowCommon StockSEC:0000950170-23-071246:0
25 of 46 declarations
About White William Richard
White William Richard is Directeur Financier. He has 46 filings in total, and, within the sampled recent filings, the transactions run from 2021-05-04 to 2025-12-09, with EUR 0 of buys and EUR 510474 of sells, the most frequent transaction nature being Levée d'options. He is also linked to Akero Therapeutics, Inc. as Chief Financial Officer, and to Disc Medicine, Inc. and Ventyx Biosciences, Inc. as Director.